KEGG   DRUG: Crenezumab
Entry
D10101                      Drug                                   
Name
Crenezumab (USAN);
Crenezumab (genetical recombination) (JAN)
Formula
C6348H9796N1688O2010S44
Exact mass
143242.3925
Mol weight
143330.75
Sequence
(Heavy chain)
EVQLVESGGG LVQPGGSLRL SCAASGFTFS SYGMSWVRQA PGKGLELVAS INSNGGSTYY
PDSVKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCASGD YWGQGTTVTV SSASTKGPSV
FPLAPCSRST SESTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ SSGLYSLSSV
VTVPSSSLGT KTYTCNVDHK PSNTKVDKRV ESKYGPPCPP CPAPEFLGGP SVFLFPPKPK
DTLMISRTPE VTCVVVDVSQ EDPEVQFNWY VDGVEVHNAK TKPREEQFNS TYRVVSVLTV
LHQDWLNGKE YKCKVSNKGL PSSIEKTISK AKGQPREPQV YTLPPSQEEM TKNQVSLTCL
VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS RLTVDKSRWQ EGNVFSCSVM
HEALHNHYTQ KSLSLSLG
(Light chain)
DIVMTQSPLS LPVTPGEPAS ISCRSSQSLV YSNGDTYLHW YLQKPGQSPQ LLIYKVSNRF
SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCSQSTHVP WTFGQGTKVE IKRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
(Disulfide bridge: H22-H96, H126-L219, H139-H195, H218-H'218, H221-H'221, H253-H313, H359-H417, H'22-H'96, H'126-L'219, H'139-H'195, H'253-H'313, H'359-H'417, L23-L93, L139-L199, L'23-L'199)
  Type
Peptide
Efficacy
Dementia therapeutic agent
  Type
Monoclonal antibody
Comment
Treatment of Alzheimer's disease
Target
Amyloid beta [CPD:C16514 C16515]
Other DBs
CAS: 1095207-05-8
PubChem: 135626819
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system